Literature DB >> 18243409

CT-guided permanent brachytherapy for patients with medically inoperable early-stage non-small cell lung cancer (NSCLC).

Rafael Martínez-Monge1, María Pagola, Isabel Vivas, José María López-Picazo.   

Abstract

Seven patients with early stage T1N0M0 NSCLC who had medical contraindications for surgical resection were treated with CT-guided percutaneous implantation of (103)Pd or (125)I seeds. After the procedure, two patients developed pneumothorax and hemo/pneumothorax that was managed with aspirative drainage. One patient developed a focal pneumonitis 3 months after the procedure. After a median follow-up of 13 months (4.6-41.0+ months), no patient has developed local or regional failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18243409     DOI: 10.1016/j.lungcan.2007.12.016

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  19 in total

1.  The combined treatment of CT-guided percutaneous 125I seed implantation and chemotherapy for non-small-cell lung cancer.

Authors:  Shengchu Zhang; Yihu Zheng; Panpan Yu; Fuxiang Yu; Qiyu Zhang; Yinxiang Lv; Xiaoxi Xie; Yunxiao Gao
Journal:  J Cancer Res Clin Oncol       Date:  2011-09-16       Impact factor: 4.553

2.  Sodium glycididazole enhances the efficacy of combined iodine-125 seed implantation and chemotherapy in patients with non small-cell lung cancer.

Authors:  Qing Zhang; Dao-Qing Wang; Yu-Fen Wu
Journal:  Oncol Lett       Date:  2015-03-16       Impact factor: 2.967

Review 3.  Primary Treatment Options for High-Risk/Medically Inoperable Early Stage NSCLC Patients.

Authors:  Guy C Jones; Jason D Kehrer; Jenna Kahn; Bobby N Koneru; Ram Narayan; Tarita O Thomas; Kevin Camphausen; Minesh P Mehta; Aradhana Kaushal
Journal:  Clin Lung Cancer       Date:  2015-04-23       Impact factor: 4.785

4.  Clinical efficacy of computed tomography-guided iodine-125 seed implantation therapy in patients with advanced spinal metastatic tumors.

Authors:  Liyun Zhang; Jian Lu; Zhongmin Wang; Yingsheng Cheng; Gaojun Teng; Kemin Chen
Journal:  Onco Targets Ther       Date:  2015-12-18       Impact factor: 4.147

5.  CT-guided 125I brachytherapy on pulmonary metastases after resection of colorectal cancer: A report of six cases.

Authors:  Shuyuan Shi; Jingkui Yang; Daqiang Sun
Journal:  Oncol Lett       Date:  2014-10-30       Impact factor: 2.967

6.  Palliative treatment of pelvic bone tumors using radioiodine (125I) brachytherapy.

Authors:  Chongren Wang; Zhengqi Chen; Wei Sun; Yisilamu Yasin; Chuanyin Zhang; Xiaojun Ma; Jian Chen; Jiakang Shen; Yingqi Hua; Zhengdong Cai
Journal:  World J Surg Oncol       Date:  2016-11-25       Impact factor: 2.754

7.  Dosimetric comparison of CT-guided iodine-125 seed stereotactic brachytherapy and stereotactic body radiation therapy in the treatment of NSCLC.

Authors:  Ranran Li; Ying Zhang; Yuan Yuan; Qi Lin; Jianjian Dai; Ruicai Xu; Xudong Hu; Mingyong Han
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

8.  Treating cancerous large airway stenosis with staging radioactive particle implantation guided by computed tomography and fiber bronchoscopy: a clinical study.

Authors:  Yu Mao; Xiuyan Yang; Ming Li; Wei Guo; Wenhua Zhang
Journal:  World J Surg Oncol       Date:  2017-08-03       Impact factor: 2.754

9.  Licochalcone A Inhibits the Proliferation of Human Lung Cancer Cell Lines A549 and H460 by Inducing G2/M Cell Cycle Arrest and ER Stress.

Authors:  Chenyu Qiu; Tingting Zhang; Wenxin Zhang; Lina Zhou; Bin Yu; Wei Wang; Zhihong Yang; Zhiguo Liu; Peng Zou; Guang Liang
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

10.  Combination of Iodine-125 brachytherapy and chemotherapy for locally recurrent stage III non-small cell lung cancer after concurrent chemoradiotherapy.

Authors:  Xiaojuan Yu; Jin Li; Xiaoming Zhong; Jingdong He
Journal:  BMC Cancer       Date:  2015-10-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.